Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04343534 · ClinicalTrials.gov registry record
Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 494
- Enrollment target
NCT04343534: Completed study, sponsored by Massachusetts General Hospital.
NCT04343534 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 494 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04343534 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 494 participants
- Enrollment target
Study Summary
The purpose of this study is to test two differently worded versions of the Shared Decision Making Process scale in a sample of adults who have recently made a decision about treatment of depression. The main goals are to gather evidence of reliability, to test whether the generic version has similar psychometric performance to the original, and to extend generalizability of the findings to younger adults.
Primary Outcome
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores for both versions of the scale range from 0-4 where higher values indicate a better shared decision making process occurred.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2020-04-29 |
| Est. Completion | 2020-12-30 |
What the finished NCT04343534 record still lists
NCT04343534 is an observational study that tracks outcomes without assigning an intervention. The registered 494 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04343534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04343534 about?
NCT04343534 is a clinical study titled "Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression". The purpose of this study is to test two differently worded versions of the Shared Decision Making Process scale in a sample of adults who have recently made a decision about treatment of depression. The main goals are to gather evidence of reliability, to test whether the generic version has simila...
What is the current status of trial NCT04343534?
This trial is currently completed. The enrollment target is 494 participants. The study started on 2020-04-29. Estimated completion is 2020-12-30.
Who is sponsoring clinical trial NCT04343534?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI